A phase IIa open-label dose-escalation study using ICX-RHY to enhance the aesthetic appearance of nasolabial folds Clinical efficacy analysis

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A phase IIa open-label study using ICX-RHY to enhance the aesthetic appearance of facial skin imperfections Clinical efficacy analysis

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A prospective single centre, open label, pilot study to evaluate the safety of ICXP007 plus standard of care, for the treatment of lower extremity chronic, neuropathic diabetic foot ulcers The primary safety objective is to determine the safety of ICXP007 plus standard of care in the treatment of chronic diabetic foot ulcers. The primary efficacy objective is to determine the efficacy...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A phase IIa uncontrolled study to evaluate hair growth in subjects with male-pattern baldness using a cell suspension of expanded autologous dermal papilla cells (ICX-TRC) To determine the efficacy of ICX-TRC in androgenetic alopecia

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A prospective placebo controlled phase II study to evaluate the use of allogeneic fibroblasts for the treatment of skin erosions in recessive dystrophic epidermolysis bulllosa People suffering from the fragile skin disorder recessive dystrophic epidermolysis bullosa (RDEB) have wounds that are chronically inflamed, don't heal, progress to scarring and are at risk for turnin...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Allogeneic fibroblast cell therapy for dystrophic epidermolysis bullosa Background and study aims This research study concerns individuals with the inherited blistering skin disease known as dystrophic epidermolysis bullosa (DEB). This a very severe condition in which ski...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A prospective, multi-centre, double blind, randomized, placebo controlled trial to evaluate the safety and efficacy of ICXP007 in a phase III trial with four-layer therapeutic compression, for treatment of non-infected skin leg ulcers, due to venous insufficiency To evaluate the safety and efficacy of ICXP007 in achieving 100% closure of non-infected skin ulcers of greater than 3 months duration due to venous insufficiency with four layer bandage compression t...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune